Alembic Pharmaceuticals

#4135

Rank

$2.09B

Marketcap

India

Country

Leadership team

Mr. Chirayu Ramanbha Amin (Exec. Chairman & CEO)

Mr. Pranav Chirayu Amin (MD & Exec. Director)

Mr. Shaunak Chirayu Amin (MD & Exec. Director)

Products/ Services

Manufacturing, Pharmaceutical

Number of Employees

1,000 - 20,000

Headquarters

Vadodara, Gujarat, India

Established

1907

Net Income

20M - 100M

Revenue

500M - 1B

Traded as

APLLTD.NS

Social Media

URL

https://alembicpharmaceuticals.com

Overview

Location

Recognition and Award

References

Summary

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

History

Alembic Pharmaceuticals Ltd. initially began as Alembic Chemical Works where it started manufacturing tincture and alcohol at its unit at Vadodara in 1907. The company eventually entered into manufacturing cough syrups, vitamins, tonics and sulphur drugs. Further, Alembic entered into production of penicillin in the 1960s. This dedicated Alembic plant for the manufacture of penicillin was inaugurated by Lal Bahadur Shastri in the year 1961, the then Prime Minister of India. Alembic soon also initiated bulk production of vitamin B12. In the antibiotic section, soon after initiation of penicillin manufacture, Alembic began the production of erythromycin in 1971 for first time in India. Alembic also incorporated and launched the 'Althrocin' brand of erythromycin. In the year, 1997, Althrocin became the top selling brand of erythromycin in India.

In 2000, Alembic received ISO 14000 certification for its Vadodara facility.In 2010, Alembic Pharmaceutical Ltd. demerged from Alembic Ltd. subsequent to the allotment of 133,515,914 equity shares of ?2 each to the shareholders of Alembic Ltd. This made the shareholding of Alembic Ltd. in Alembic Pharmaceutical to reduce from 100% to 29.18%.In 2011, the equity shares of Alembic Pharmaceuticals Ltd. were listed on the Bombay Stock Exchange and National Stock Exchange of India.

Mission

Alembic's mission is to provide quality healthcare products, ethically and cost-effectively, to meet the needs of patients, healthcare providers and other stakeholders.

Vision

Alembic's vision is to be a leader in the healthcare industry and to make a positive contribution to society, by meeting the needs of patients and other stakeholders.

Key Team

Mr. Raj Kumar Shreeram Baheti (Director of Fin., CFO & Exec. Director)

Mr. Vinod Kamath (Pres of Operations)

Dr. J. Venkat Raman M. S., Ph.D. (Chief Scientific Officer)

Mr. Charandeep Singh Saluja (Company Sec. & Compliance Officer)

Mr. Udit C. Amin (Chief Bus. Devel. Officer)

Mr. Chandrahas Shetty (Sr. VP of HR)

Mr. Gautam Chatterjee (Sr. VP)

Recognition and Awards

Alembic Pharmaceuticals has won several awards including the Pharmexcil Outstanding Exporter Award , Health Care Federation of India Excellence Award , and the India Business Leadership Award